About Us

HTD Biosystems is a contract formulation development lab that provides services for accelerating the development of parenteral drugs, biosimilars, and vaccines.

HTD has worked and collaborated with other companies, governments, and academia. Our researchers have helped other companies develop their products. An example of a product that was formulated and developed at HTD Biosystems for a Japanese biotech company, is a liposomal formulation against graft-versus-host disease (GvHD) associated with hematopoietic stem cell transplantation (HSCT). This product is now in Phase II clinical trials.